In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million repayment order. This decision marks another setback for the former ...

Once convicted of securities fraud, Shkreli now focuses primarily on stock trading. He shared a short position in Opendoor on X this week, drawing the ire of bullish retail investors. Martin Shkreli ...

NEW YORK — A federal appeals court upheld the securities fraud conviction against former drug company CEO Martin Shkreli, known as “Pharma Bro,” on Thursday, along with a $7.3 million forfeiture of ...

In this Aug. 3, 2017, file photo, Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in Brooklyn, New York. automation Martin Shkreli's lifetime ban ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an order to return $64.6 million ...

NEW YORK CITY -- Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal ...

Companies founded by notorious "Pharma Bro" Martin Shkreli have agreed to pay up to $28 million to settle a class-action lawsuit related to claims they illegally thwarted competition to the ...

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. What Happened: On Saturday, in a post on X, ...

WASHINGTON — The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an order to return ...